KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $521,100 | +23.4% | 30,000 | 0.0% | 0.44% | +40.1% |
| Q2 2023 | $422,400 | +130674.0% | 30,000 | 0.0% | 0.32% | +25.3% |
| Q1 2023 | $323 | -28.1% | 30,000 | 0.0% | 0.25% | -20.2% |
| Q4 2022 | $449 | -99.9% | 30,000 | 0.0% | 0.32% | +17.0% |
| Q3 2022 | $385,000 | +32.3% | 30,000 | 0.0% | 0.27% | +27.8% |
| Q2 2022 | $291,000 | -2.3% | 30,000 | 0.0% | 0.21% | -1.4% |
| Q1 2022 | $298,000 | -15.6% | 30,000 | 0.0% | 0.22% | -5.7% |
| Q4 2021 | $353,000 | +3.2% | 30,000 | 0.0% | 0.23% | -2.1% |
| Q3 2021 | $342,000 | +22.6% | 30,000 | +50.0% | 0.23% | +39.5% |
| Q2 2021 | $279,000 | – | 20,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |